Company intelligence / Profile preview

Tissu

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Tissu (often referred to as Tissu.ai) is a digital health and biotechnology company that provides an AI-powered platform for digital pathology. The company's technology is designed to automate and enhance the analysis of tissue samples, particularly in oncology, to improve diagnostic accuracy and speed. By leveraging deep learning algorithms, Tissu's platform assists pathologists in identifying and quantifying biomarkers and morphological features in histological slides. The company aims to streamline clinical workflows and support pharmaceutical research by providing high-resolution, data-driven insights from biopsy samples.

Therapeutic areas: Oncology
Modalities: Artificial IntelligenceDigital PathologySoftware as a Service
Industry: Pathology

Beyond the preview

Go deeper on Tissu.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissu.

Explore the full profile